FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562181660> ?p ?o ?g. }

• W2562181660 endingPage "180" @default.
• W2562181660 startingPage "173" @default.
• W2562181660 abstract "Background Updated evidence-based guidelines for the management of atrial fibrillation (AF) necessitate patient review, particularly with respect to oral anticoagulants, to ensure maximum health gain around stroke prophylaxis. Objective To quantify the level of anticoagulation utilisation in patients with a CHA2DS2-VASc ≥1/≥2 (male/female) according to evidence-based guidelines and to assess the impact of a pharmacist-led intervention to optimise therapy. Setting Fifteen general medical practices in Liverpool, North-West England with a practice population of 99,129. Method GRASP-AF software was employed to interrogate patient electronic medical records to identify and risk stratify AF patients (using CHA2DS2-VASc). A pharmacist then reviewed the medical records of those of patients not anticoagulated and with a CHA2DS2-VASc ≥1/≥2 (male/female). Recommendations were discussed with a general practitioner (GP) and those patients in whom the need for anticoagulation was agreed were invited for a consultation with either the pharmacist or GP and therapy optimised where appropriate. The GPs were responsible for managing those patients referred for diagnosis confirmation or further specialist opinion. Main outcome measure Proportion of patients eligible/not eligible for anticoagulation; proportions in whom anticoagulants initiated, refused, antiplatelets discontinued. Results Five hundred and twenty-three patients (31% of patients identified with AF and a CHA2DS2-VASc ≥1/≥2 (male/female)) were not receiving an anticoagulant (26 subsequently died or left the practice leaving 497). Three hundred and eighty-two (77%) pharmacist recommendations to a GP were agreed without modification. Following outcomes of diagnostic investigations and specialist referrals, 202 (41%) patients were candidates for anticoagulation, 251 (51%) were not eligible for anticoagulation, 103 (21%) were anticoagulated (56 warfarin, 47 DOAC). Conclusion A pharmacist-led intervention re-aligned oral anticoagulant therapy to the latest evidence based guidelines for stroke prophylaxis, whilst simultaneously correcting the over-utilisation of antiplatelet therapy." @default.
• W2562181660 created "2017-01-06" @default.
• W2562181660 creator A5015086877 @default.
• W2562181660 creator A5015310043 @default.
• W2562181660 date "2017-01-03" @default.
• W2562181660 modified "2023-09-24" @default.
• W2562181660 title "Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: a pharmacist-led intervention" @default.
• W2562181660 cites W1497225051 @default.
• W2562181660 cites W1575580373 @default.
• W2562181660 cites W1977849235 @default.
• W2562181660 cites W1994295201 @default.
• W2562181660 cites W1995139028 @default.
• W2562181660 cites W2004217778 @default.
• W2562181660 cites W2009752458 @default.
• W2562181660 cites W2013763124 @default.
• W2562181660 cites W2023143117 @default.
• W2562181660 cites W2023992279 @default.
• W2562181660 cites W2029020502 @default.
• W2562181660 cites W2038329412 @default.
• W2562181660 cites W2042639094 @default.
• W2562181660 cites W2046991340 @default.
• W2562181660 cites W2055663889 @default.
• W2562181660 cites W2061389005 @default.
• W2562181660 cites W2079470087 @default.
• W2562181660 cites W2085645128 @default.
• W2562181660 cites W2096246254 @default.
• W2562181660 cites W2097854437 @default.
• W2562181660 cites W2103245453 @default.
• W2562181660 cites W2105486760 @default.
• W2562181660 cites W2110072219 @default.
• W2562181660 cites W2114775432 @default.
• W2562181660 cites W2120195986 @default.
• W2562181660 cites W2121394112 @default.
• W2562181660 cites W2122517461 @default.
• W2562181660 cites W2128415369 @default.
• W2562181660 cites W2130787002 @default.
• W2562181660 cites W2132505348 @default.
• W2562181660 cites W2136489990 @default.
• W2562181660 cites W2138135303 @default.
• W2562181660 cites W2144644565 @default.
• W2562181660 cites W2146701144 @default.
• W2562181660 cites W2147018083 @default.
• W2562181660 cites W2149388786 @default.
• W2562181660 cites W2150085535 @default.
• W2562181660 cites W2150514798 @default.
• W2562181660 cites W2159730165 @default.
• W2562181660 cites W2162508946 @default.
• W2562181660 cites W2165762371 @default.
• W2562181660 cites W2171868042 @default.
• W2562181660 cites W2194640142 @default.
• W2562181660 cites W2338633208 @default.
• W2562181660 cites W3030533492 @default.
• W2562181660 cites W4241818887 @default.
• W2562181660 cites W4245708227 @default.
• W2562181660 doi "https://doi.org/10.1007/s11096-016-0419-x" @default.
• W2562181660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28050712" @default.
• W2562181660 hasPublicationYear "2017" @default.
• W2562181660 type Work @default.
• W2562181660 sameAs 2562181660 @default.
• W2562181660 citedByCount "13" @default.
• W2562181660 countsByYear W25621816602018 @default.
• W2562181660 countsByYear W25621816602020 @default.
• W2562181660 countsByYear W25621816602021 @default.
• W2562181660 countsByYear W25621816602022 @default.
• W2562181660 countsByYear W25621816602023 @default.
• W2562181660 crossrefType "journal-article" @default.
• W2562181660 hasAuthorship W2562181660A5015086877 @default.
• W2562181660 hasAuthorship W2562181660A5015310043 @default.
• W2562181660 hasBestOaLocation W25621816602 @default.
• W2562181660 hasConcept C104863432 @default.
• W2562181660 hasConcept C126322002 @default.
• W2562181660 hasConcept C127413603 @default.
• W2562181660 hasConcept C159110408 @default.
• W2562181660 hasConcept C177713679 @default.
• W2562181660 hasConcept C187212893 @default.
• W2562181660 hasConcept C194828623 @default.
• W2562181660 hasConcept C195910791 @default.
• W2562181660 hasConcept C2426938 @default.
• W2562181660 hasConcept C2779161974 @default.
• W2562181660 hasConcept C2779457091 @default.
• W2562181660 hasConcept C2780645631 @default.
• W2562181660 hasConcept C2780665704 @default.
• W2562181660 hasConcept C2908647359 @default.
• W2562181660 hasConcept C512399662 @default.
• W2562181660 hasConcept C71924100 @default.
• W2562181660 hasConcept C78519656 @default.
• W2562181660 hasConcept C99454951 @default.
• W2562181660 hasConceptScore W2562181660C104863432 @default.
• W2562181660 hasConceptScore W2562181660C126322002 @default.
• W2562181660 hasConceptScore W2562181660C127413603 @default.
• W2562181660 hasConceptScore W2562181660C159110408 @default.
• W2562181660 hasConceptScore W2562181660C177713679 @default.
• W2562181660 hasConceptScore W2562181660C187212893 @default.
• W2562181660 hasConceptScore W2562181660C194828623 @default.
• W2562181660 hasConceptScore W2562181660C195910791 @default.
• W2562181660 hasConceptScore W2562181660C2426938 @default.
• W2562181660 hasConceptScore W2562181660C2779161974 @default.
• W2562181660 hasConceptScore W2562181660C2779457091 @default.

• next